Could poop pills boost cancer treatment? new study tests gut bacteria transplant
NCT ID NCT07292142
Summary
This study is testing whether adding a fecal microbiota transplant (FMT)—which transfers gut bacteria from a healthy donor—to standard pre-surgery chemotherapy and immunotherapy is safe and feasible for people with aggressive triple-negative breast cancer. Researchers want to see if changing the gut microbiome can help the body respond better to cancer treatment. The study will first observe patients on standard treatment, then test the FMT procedure in a second group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
London Health Sciences Center
London, Ontario, Canada
Contact Email: •••••@•••••
-
The Ottawa Hospital Cancer Centre
Ottawa, Ontario, Canada
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.